The U.S. District Court for the District of New Jersey has ruled in United Therapeutics Corporation‘s favor in the…
admin
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by admin
The first results of AMBITION, a large pulmonary arterial hypertension clinical trial, will be presented this month at the…
Sorrento Therapeutics, Inc., a late-stage clinical oncology company, has announced that it will advance with its immunotherapy targeting WNT1-Inducible…
UCLA researchers have shown that oxidized lipids may contribute to pulmonary hypertension (PH), a progressive and incurable disease…
Pulmonary Hypertension & Viagra: Researchers Discover Novel Mechanisms of Sildenafil for Disease
A group of researchers from the University of Pécs, Hungary, have attempted to understand the mechanism by which pulmonary…
Although clinically unexplored, pulmonary hypertension (PH) in the setting of idiopathic pulmonary fibrosis (IPF) is a significant…
Systemic sclerosis (SSc) is a disease that affects multiple organs, with the heart being frequently affected and correlating with…
GeNo LLC, a pharmaceutical company developing a line of innovative nitric oxide drug products, is currently testing next-generation inhaled…
A team of researchers from the University Medical Center Groningen in Holland, has identified three baseline variables that can…
A team of researchers from the Imperial College London, UK, has preformed a three-dimensional speckle tracking (3D-ST) study and…
A team of researchers has published their results assessing left atrial volume in chronic thromboembolic pulmonary hypertension (CTEPH)…
Study Shows Patients With Pulmonary Arterial Hypertension Benefit From Specialized Care Centers
Expert medical specialty care for rare diseases like pulmonary arterial hypertension was recently the subject of review in an article…